|
Carmustine Clinical Trials
5 actively recruiting trials across 4 locations
Also known as: BCNU, BCNU,bis-chloronitrosourea, Becenum, Becenun, BiCNU +12 more
Pipeline
Phase 1: 1Phase 2: 3Phase 1/2: 1
Top Sponsors
- Washington University School of Medicine2
- VBI Vaccines Inc.1
- Leland Metheny1
- City of Hope Medical Center1
Indications
- Cancer5
- Glioblastoma Multiforme2
- Supratentorial Glioblastoma1
- Supratentorial Gliosarcoma1
- Recurrent Hodgkin Lymphoma1
St Louis, Missouri2 trials
CNS-Relapse Prevention in High-Risk Diffuse Large B-cell Lymphoma With Thiotepa-based Autologous Stem Cell Transplant
Washington University School of Medicine
Phase 2
Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)
Washington University School of Medicine/St. Louis Children's Hospital
Phase 1
Duarte, California1 trial
Irvine, California1 trial
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
University of California, Irvine
Phase 1/2
Cleveland, Ohio1 trial
hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
University Hospitals Cleveland Medical Center
Phase 2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.